Q4 2025 earnings call recap: 2026 revenue guidance, ExPERT DTx launch, SPL pipeline, margins and risks—read key takeaways now.

O'Connell projected, "We expect to read out ALTITUDE-AD late this year, inclusive of key clinical efficacy and safety measures." He indicated that results from this study would inform development ...

In India, the rise of heart disease is alarming, striking younger populations with increasing frequency. To combat this ...

The gist of the “Stranger Things effect” is that there are two very distinct zeitgeists—and they’re harmonizing—inspiring ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...

New respiratory research to be presented at TSANZSRS 2026 spans genomics, rare lung disease, COPD and life-course lung health. The program ...

After previous setbacks with the program, investors largely brushed aside ocular-focused Kodiak Sciences Inc.’s anticipated ...

Interview I was at a press luncheon at KubeCon Europe this week when, to my surprise, who should sit down next to me but long ...

BIO-Europe Spring 2026 brought together more than 3,700 innovators in the life sciences industry all under the same roof.

Like tiny photobombers, cosmic anomalies resembling small, bright red points show up in almost every snapshot taken by the ...

Chris Carla, the general manager of portfolio and programs at Xbox, discussed how game developers can prepare for developing ...